Itron (NASDAQ:ITRI - Get Free Report) had its target price boosted by stock analysts at JPMorgan Chase & Co. from $107.00 to $109.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an "overweight" rating on the scientific and technical instruments company's stock. JPMorgan Chase & Co.'s price objective indicates a potential upside of 17.37% from the stock's previous close.
Several other equities analysts have also weighed in on ITRI. Zacks Research lowered shares of Itron from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 19th. Robert W. Baird set a $125.00 target price on shares of Itron in a report on Wednesday, July 29th. Oppenheimer reiterated an "outperform" rating on shares of Itron in a research note on Wednesday. Seaport Research Partners reissued a "buy" rating and issued a $150.00 price target on shares of Itron in a report on Wednesday, July 29th. Finally, Needham & Company LLC increased their price target on shares of Itron from $128.00 to $137.00 and gave the company a "buy" rating in a report on Tuesday. Nine equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $129.20.
Get Our Latest Report on Itron
Itron Stock Performance
Itron stock traded down $1.68 during midday trading on Wednesday, reaching $92.87. 475,364 shares of the company's stock were exchanged, compared to its average volume of 820,586. The company has a debt-to-equity ratio of 0.96, a quick ratio of 2.29 and a current ratio of 2.75. The stock's 50-day simple moving average is $91.26 and its 200 day simple moving average is $91.10. The firm has a market cap of $4.07 billion, a price-to-earnings ratio of 15.47, a P/E/G ratio of 1.05 and a beta of 1.32. Itron has a 52 week low of $77.77 and a 52 week high of $142.00.
Itron (NASDAQ:ITRI - Get Free Report) last posted its earnings results on Tuesday, October 27th. The scientific and technical instruments company reported $1.94 earnings per share for the quarter, topping analysts' consensus estimates of $1.56 by $0.38. Itron had a return on equity of 19.26% and a net margin of 11.90%. The business had revenue of $599.33 million for the quarter, compared to analyst estimates of $595.50 million. During the same period in the previous year, the firm earned $1.54 EPS. The firm's revenue was up 3.0% compared to the same quarter last year. On average, analysts expect that Itron will post 6.41 earnings per share for the current fiscal year.
Insider Transactions at Itron
In other news, CFO Joan Hooper sold 4,406 shares of the business's stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $98.86, for a total value of $435,577.16. Following the completion of the sale, the chief financial officer owned 117,113 shares of the company's stock, valued at approximately $11,577,791.18. The trade was a 3.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 331 shares of the company's stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $98.79, for a total transaction of $32,699.49. Following the completion of the transaction, the senior vice president owned 12,683 shares in the company, valued at $1,252,953.57. This trade represents a 2.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 17,903 shares of company stock worth $1,753,521 over the last quarter. 1.77% of the stock is currently owned by corporate insiders.
Institutional Trading of Itron
A number of institutional investors have recently bought and sold shares of the business. Assenagon Asset Management S.A. increased its holdings in Itron by 160.4% in the 2nd quarter. Assenagon Asset Management S.A. now owns 336,710 shares of the scientific and technical instruments company's stock valued at $29,136,000 after buying an additional 207,416 shares during the period. Readystate Asset Management LP bought a new stake in shares of Itron during the 2nd quarter worth approximately $1,809,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Itron by 12.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company's stock worth $60,359,000 after acquiring an additional 73,020 shares during the period. WCM Investment Management LLC boosted its position in shares of Itron by 49.5% during the 1st quarter. WCM Investment Management LLC now owns 87,175 shares of the scientific and technical instruments company's stock worth $7,312,000 after acquiring an additional 28,857 shares in the last quarter. Finally, John G Ullman & Associates Inc. boosted its position in shares of Itron by 37.4% during the 1st quarter. John G Ullman & Associates Inc. now owns 80,656 shares of the scientific and technical instruments company's stock worth $7,229,000 after acquiring an additional 21,975 shares in the last quarter. Institutional investors own 96.19% of the company's stock.
More Itron News
Here are the key news stories impacting Itron this week:
- Positive Sentiment: Q3 earnings beat expectations: Itron reported adjusted EPS of $1.94, well above the $1.56 analyst consensus, while revenue rose 3% year over year to $599.3 million, slightly exceeding estimates. Net income increased to $71.4 million, supported by stronger operating margins. Itron Stock Jumps as Q3 Earnings Showcase Margin Strength
- Positive Sentiment: Recurring revenue and backlog improved: Annual recurring revenue increased 25% to $423 million, while total backlog reached $4.3 billion. Operating cash flow was $102 million and free cash flow was $96 million, providing additional support for the bullish earnings reaction. Itron Q3 Revenue Rises 3% to $599 Million
- Positive Sentiment: Full-year outlook was maintained or raised: Itron projected fourth-quarter revenue of $621 million to $636 million and full-year 2026 revenue of $2.37 billion to $2.385 billion. Needham raised its price target from $128 to $137 and upgraded its view to “buy,” implying substantial upside from current levels. Needham Itron Price Target
- Neutral Sentiment: Analyst views remain mixed: BNP Paribas Exane cut its target from $115 to $105 but retained an “outperform” rating. The lower target may limit enthusiasm, although it still indicates potential appreciation. BNP Paribas Exane Lowers Itron Price Target
- Negative Sentiment: Insider selling is a cautionary signal: Company insiders reportedly made no purchases and 42 sales during the past six months. While these transactions may reflect portfolio or compensation decisions, the absence of insider buying could weigh on sentiment.
Itron Company Profile
(
Get Free Report)
Itron, Inc is a technology company that provides solutions to utilities and cities for managing electricity, natural gas, and water resources. Its offerings help organizations measure consumption, collect and analyze data, improve operational efficiency, and support more reliable and sustainable delivery of essential services.
The company's portfolio includes smart meters, advanced metering infrastructure, communications networks, sensors, data management systems, and utility software.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.